Senior Manager
Mirum Pharmaceuticals
Senior Manager
Mirum Pharmaceuticals
ASBT inhibitors for rare liver diseases
MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
Mirum Pharmaceuticals is seeking an experienced, highly motivated, and detail-oriented Senior Manager, Commercial Supply Chain to support its growing global commercial portfolio and new product launches. This position will be primarily responsible for managing domestic and international commercial distribution, inventory management, and order-to-cash (O2C) operations to ensure timely, accurate, and compliant product delivery across global markets. In addition, the role will support end-to-end (E2E) commercial supply planning activities, including demand and supply alignment, labeling and packaging coordination, and finished product supply execution, while developing the capabilities to provide effective planning backup and ensure business continuity. The successful candidate will collaborate closely with cross-functional teams and external supply chain partners to drive operational excellence, maintain uninterrupted commercial supply, and support patient access.
JOB FUNCTIONS/RESPONSIBILITIES
QUALIFICATIONS
Education /Experience:
Knowledge, Skills and Abilities:
The salary range for this position is $180,000 to $190,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
ASBT inhibitors for rare liver diseases
Mirum develops therapies for rare liver diseases, led by LIVMARLI (maralixibat), an oral ASBT inhibitor that reduces bile acid buildup and itching in Alagille syndrome and other cholestatic conditions. It is pursuing LIVMARLI for additional rare diseases such as PFIC and biliary atresia and developing volixibat for primary sclerosing cholangitis and primary biliary cholangitis. The company combines drug development with commercialization in the United States and other major markets, working with physicians, payers, and patient groups to improve access. Its goal is to bring effective therapies to patients with rare liver diseases and build a sustainable commercial presence in key markets.
Explore more opportunities at Mirum Pharmaceuticals